Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
about
3D-Printed Scaffolds and Biomaterials: Review of Alveolar Bone Augmentation and Periodontal Regeneration ApplicationsNanoparticulate adjuvants and delivery systems for allergen immunotherapyRecent developments of functional scaffolds for craniomaxillofacial bone tissue engineering applicationsLong-term delivery of protein therapeuticsCombinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes TargetingCombinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiationIn vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochlorideBacterial-Derived Polymer Poly-γ-Glutamic Acid (γ-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical ApplicationsPolymeric and Solid Lipid Nanoparticles for Sustained Release of Carbendazim and Tebuconazole in Agricultural ApplicationsHydrophilization of poly(caprolactone) copolymers through introduction of oligo(ethylene glycol) moieties.Collagen-coated polycaprolactone microparticles as a controlled drug delivery system.Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.Polymeric implants for the delivery of green tea polyphenols.Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model.Mineralization content alters osteogenic responses of bone marrow stromal cells on hydroxyapatite/polycaprolactone composite nanofiber scaffoldsIn vitro generation of mechanically functional cartilage grafts based on adult human stem cells and 3D-woven poly(epsilon-caprolactone) scaffolds.Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury.Synthesis and self-assembly behavior of a biodegradable and sustainable soybean oil-based copolymer nanomicelleBioresorbable Vesicles Formed through Spontaneous Self-Assembly of Amphiphilic Poly(ethylene oxide)-block-polycaprolactone.Degradation of Poly(ε-caprolactone) by thermophilic Streptomyces thermoviolaceus subsp. thermoviolaceus 76T-2.Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization.Combination of bone marrow concentrate and PGA scaffolds enhance bone marrow stimulation in rabbit articular cartilage repair.Biodegradable polycaprolactone (PCL) nanosphere encapsulating superoxide dismutase and catalase enzymes.Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon CancerEnhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adductsCurrent advances in sustained-release systems for parenteral drug delivery.Nanostructured thin film polymer devices for constant-rate protein deliveryInvestigation of physical properties of a polycaprolactone dermal filler when mixed with lidocaine and lidocaine/epinephrine.Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial.Biodegradable polymers for microencapsulation of drugs.Doxorubicin-Loaded PEG-PCL-PEG Micelle Using Xenograft Model of Nude Mice: Effect of Multiple Administration of Micelle on the Suppression of Human Breast Cancer.Controlled release of liraglutide using thermogelling polymers in treatment of diabetesThe Antidepressant Effect of L-Tyrosine-Loaded Nanoparticles: Behavioral Aspects.Role of in vitro release models in formulation development and quality control of parenteral depots.Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspectsPolymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.Recent advances in polymeric microspheres for parenteral drug delivery--part 1.Biodegradable polymers as encapsulation materials for cosmetics and personal care markets.Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.
P2860
Q26745744-D4C982BD-F6C4-492A-BB79-34460789186AQ26825418-50A771D1-D7CE-4EF7-AC62-4F4F9F871FABQ26827234-9C0ED83C-E436-4FBE-829B-AF4A389598F4Q26860505-7E34B503-6E5E-442D-B371-8DD783406C4CQ27329596-C084B28B-590D-499C-9086-615AAB2F84F6Q28072997-5272534D-92AF-49F5-8A5A-EF9BA4E7F1FAQ28478584-AFA27CBD-CE51-4D1D-8D80-87B124EDDF83Q28833579-6D877012-9ADB-4975-A295-4C998DF15A54Q29248031-C6541F57-71E1-400E-8D59-62D7245B95E1Q30387682-A90E9E0D-FB7F-41B3-AD66-976DAF254DC6Q30831334-68F9FA33-105B-4A5E-96E3-44409A1FA184Q33332637-7508AB2E-7993-47F7-AE1B-66206DBB9DB5Q33553453-220FA04A-1A52-4C91-B5EE-D633DFAF9FA1Q33564764-C6D24DDF-242A-4FCC-AA42-42BD538A2681Q33582690-D6C2527B-A78A-4DE5-890E-A8D75BD6C9C1Q33649714-08EDB72B-D19C-4A81-BDF5-7C67D26193C4Q33668567-73F30D17-B736-480E-9463-44C5DC4F8BBFQ33870573-1161FCBE-ECAB-4560-BF3E-2DEC591AEEDEQ34078236-6E9BD56F-4BFD-4388-8CF5-CB3CA9520F3DQ34219831-89859A7C-496F-4C8F-850E-D25FB97B9CB9Q34325092-E68FAEB1-8AEE-4833-97D3-FDCB5629A9D3Q34482076-DC827EC4-1215-4112-98FA-C2C589E5EDBBQ34527327-F3EFBDE1-6ECC-4E5F-8385-8F1A3ED05F80Q34969707-E20C5E14-3727-4B27-8F78-E15449D2CA94Q35768392-19482C63-675E-4BD6-8C6E-44FA1B27A52CQ35966929-7335B5F3-D7B4-4D77-B663-37FBF9F85CABQ36316931-BBDAD79D-C09D-4036-BEC2-63E433111FF8Q36344850-A577AF55-3F3A-42E3-8004-C8E9A428483BQ36434753-C1092F7F-A499-4055-B46E-BF7614AAAF7CQ36736409-C7B2CFAF-E195-44E3-B5E9-87F0EFC95604Q37002674-CEE198CE-0413-45BC-BB4F-910D3FCDDE43Q37129746-58CACAAB-6A49-4810-8DF4-F77C541B5C53Q37181542-946E1FA6-A5ED-43D5-8254-3975ECE72B2DQ37251107-27ACF932-AB00-428B-A8FA-4E2AB04212A4Q37639309-2A62D7AF-0FD0-49A6-81E4-05D165571CA9Q37801284-81D7729D-C033-4AF2-8C36-EBA8B388A7E9Q37928912-B5845070-7D1A-4573-B8DE-855548F212F4Q38029806-6DB02FD5-4816-4B6E-BB7A-79CDEB837D8FQ38052924-7902C423-8809-4CD4-B9D7-715C82DA23B3Q38063945-74302928-2A7A-431A-A26D-DB76B4D9F38C
P2860
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@ast
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@en
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@nl
type
label
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@ast
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@en
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@nl
prefLabel
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@ast
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@en
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@nl
P2093
P1476
Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
@en
P2093
P356
10.1016/J.IJPHARM.2004.01.044
P407
P577
2004-06-01T00:00:00Z